Luminal Breast Cancer Cell Lines Overexpressing ZNF703 Are Resistant to Tamoxifen through Activation of Akt/mTOR Signaling

• Xi Zhang ,

  Contributed equally to this work with: Xi Zhang, Xin Mu

  Affiliation Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

  ⨯
• Xin Mu ,

  Contributed equally to this work with: Xi Zhang, Xin Mu

  Affiliation Department of Urology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

  ⨯
• Ou Huang,

  Affiliation Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

  ⨯
• Zuoquan Xie,

  Affiliation Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

  ⨯
• Min Jiang,

  Affiliation Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

  ⨯
• Meiyu Geng ,

  * E-mail: mygeng@mail.shcnc.ac.cn (MG); kwshen@medmail.com.cn (KS)

  Affiliation Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

  ⨯
• Kunwei Shen

  * E-mail: mygeng@mail.shcnc.ac.cn (MG); kwshen@medmail.com.cn (KS)

  Affiliation Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

  ⨯